Breast/ovarian cancer
1 – 10 of 160
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Redefining Cytotechnologist Practice in Sweden : National Survey on Workload, Expanded Roles, and Future Competency Needs
- Contribution to journal › Article
-
Mark
Statin use and risk of contralateral breast cancer : an updated cohort study with landmark analysis
(2026) In European Journal of Epidemiology
- Contribution to journal › Article
-
Mark
Kunskap om ärftlig cancer – inte kopplad till långvarig oro eller sämre livskvalitet
- Contribution to specialist publication or newspaper › Specialist publication article
-
Mark
Mesothelial cells promote peritoneal invasion and metastasis of ascites-derived ovarian cancer cells through spheroid formation
- Contribution to journal › Article
-
Mark
Homologous recombination deficiency in primary ER-positive and HER2-negative breast cancer
- Contribution to journal › Article
-
Mark
Multiomics assessment of lung adenocarcinoma subtypes defined through tumor purity-adjusted DNA methylation
- Contribution to journal › Article
-
Mark
Dynamic assessment of proliferation to guide response-adapted therapy in the setting of neoadjuvant chemotherapy in ER+/HER2- breast cancer
- Contribution to journal › Article
-
Mark
Iron deficiency restrains short-term recovery in patients undergoing surgery for advanced ovarian cancer
(2026) In European Journal of Surgical Oncology
- Contribution to journal › Article
-
Mark
Quality of life, anxiety and cancer worry following hereditary cancer testing: a 6-month Swedish follow-up study
- Contribution to journal › Article
- 2025
-
Mark
High prevalence of FAP+ cancer-associated fibroblasts predicts poor outcome in patients with high-grade serous ovarian cancer with high CD8 T-cell density
- Contribution to journal › Article
